SEC Form 4 · accession 0001567619-18-000260
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Anne Szostak
Director
Period of report
Aug 7, 2018
Accepted (ET)
Aug 9, 2018 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2018 | G | 12,000 | $0.00 | D | 3,416 | I | M. Anne Szostak Trust |
| Common StockF1 | Aug 7, 2018 | G | 12,000 | $0.00 | A | 12,000 | I | 2018 Szostak IDEXX GRAT |
| Common Stock | holding | — | — | — | 584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares have been transferred from the M. Anne Szostak Trust (the 'Trust') to the 2018 Szostak IDEXX GRAT (the 'GRAT'). The reporting person is the settlor and trustee of the GRAT. The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest in the GRAT.